Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Iqvia-backed medical marketing communications platform Naxions will pump the fresh capital into R&D, new product launches and customer relations.

Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.

Leaps by Bayer has put $50m into xenotransplantation technology developer eGenesis as part of a $100m series B round that followed a $38m series A backed by Heritage Provider Network.

AiCure has picked up series C capital from investors such as Singtel Innov8 and Asahi Kasei to bolster its commercial, engineering and R&D efforts.

Axis Capital and CNO Financial Group invested in health insurance portal Healthcare.com’s second funding round, proceeds of which will support product development and other growth objectives.

Mayo Clinic Ventures pumped in a share of the proceeds for Cadence Neuroscience, which is working on biomarker-powered neuromodulation therapies for drug resistant-focal epilepsy.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Inserm spinout secured a $7.8m series B extension and boosted its portfolio with the acquisition of AVCare, a Satt Ouest Valorisation-allied business.

AstraZeneca has partnered CICC to launch a fund that will invest in Chinese startups exploiting technologies such as artificial intelligence to improve healthcare.